PL2734192T3 - Musująca postać dawkowana - Google Patents

Musująca postać dawkowana

Info

Publication number
PL2734192T3
PL2734192T3 PL13731013T PL13731013T PL2734192T3 PL 2734192 T3 PL2734192 T3 PL 2734192T3 PL 13731013 T PL13731013 T PL 13731013T PL 13731013 T PL13731013 T PL 13731013T PL 2734192 T3 PL2734192 T3 PL 2734192T3
Authority
PL
Poland
Prior art keywords
dosage form
effervescent dosage
effervescent
dosage
Prior art date
Application number
PL13731013T
Other languages
English (en)
Inventor
Mark Edward Stella
John Richard Entwisle
Jason William Newlon
Christine Louie Naykki
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PL2734192T3 publication Critical patent/PL2734192T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
PL13731013T 2012-06-12 2013-06-12 Musująca postać dawkowana PL2734192T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261658430P 2012-06-12 2012-06-12
EP13731013.2A EP2734192B1 (en) 2012-06-12 2013-06-12 Effervescent dosage form
PCT/US2013/045303 WO2013188483A1 (en) 2012-06-12 2013-06-12 Effervescent dosage form

Publications (1)

Publication Number Publication Date
PL2734192T3 true PL2734192T3 (pl) 2015-09-30

Family

ID=48672843

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13731013T PL2734192T3 (pl) 2012-06-12 2013-06-12 Musująca postać dawkowana

Country Status (12)

Country Link
US (1) US10617714B2 (pl)
EP (1) EP2734192B1 (pl)
CN (1) CN104363897A (pl)
AU (1) AU2013274378B2 (pl)
BR (1) BR112014030680B1 (pl)
CA (1) CA2876062C (pl)
ES (1) ES2541723T3 (pl)
IN (1) IN2014DN10385A (pl)
MX (1) MX368363B (pl)
PL (1) PL2734192T3 (pl)
RU (1) RU2014149581A (pl)
WO (1) WO2013188483A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2604124A1 (en) * 2011-12-16 2013-06-19 Nestec S.A. Soluble non-dairy creamer tablet surface-treated with carbohydrate
CN107787216A (zh) * 2015-06-29 2018-03-09 Elc 管理有限责任公司 用于化妆品应用的具有交联涂层的颗粒
CN107114795A (zh) * 2017-07-06 2017-09-01 胥永贵 一种弱碱补钙、苏打碱化姜制剂及其制备方法和应用
US11793876B2 (en) 2019-10-18 2023-10-24 L. Perrigo Company Bulk polyethylene glycol compositions
WO2022060310A1 (en) * 2020-09-18 2022-03-24 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising calcium carbonate, magnesium carbonat and simethicone
WO2022266359A1 (en) * 2021-06-17 2022-12-22 Ocean Spray Cranberries, Inc. Rare sugars in food and beverage products
US12053484B2 (en) 2021-10-29 2024-08-06 Medicated Chews, Llc Simethicone chewable composition
US20250281391A1 (en) * 2024-03-06 2025-09-11 Bayer Healthcare Llc Effervescent composition and method for determining bitterness perception

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1518364A (en) 1976-05-05 1978-07-19 Beecham Group Ltd Pharmaceutical composition
US4198390A (en) 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
US4396604A (en) 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
SE462014B (sv) 1983-09-28 1990-04-30 Gerhard Gergely Brusgranulat och foerfarande foer dess framstaellning
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4650669A (en) 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
GB8909793D0 (en) 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5073384A (en) 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
ATE128027T1 (de) 1991-07-01 1995-10-15 Gergely Gerhard Lutsch- oder kautablette.
AU4597293A (en) 1992-06-30 1994-01-24 Procter & Gamble Company, The Effervescent calcium supplements
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
FR2705966B1 (fr) 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
CN1192137A (zh) 1995-07-31 1998-09-02 格哈特·格戈里 有泡腾效应的咀嚼片剂
EP0788791A4 (en) 1995-09-07 1998-04-22 Otsuka Pharma Co Ltd WITH LOW PRESSURE-PRESERVED SHOWER PREPARATION
US5807577A (en) 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5888544A (en) 1996-06-20 1999-03-30 Gerhard Gergely Effervescent system for effervescent tablets and effervescent granules
DE19814256A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
GB9825033D0 (en) 1998-11-13 1999-01-13 Nycomed Pharma As Process
US6296868B1 (en) 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
DE19859231A1 (de) 1998-12-21 2000-06-29 Kurt Heinz Bauer Schäumende Antacida-Suspensionstabletten
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US20030235613A1 (en) 2002-06-19 2003-12-25 Cts Chemical Industries Ltd. Popping oral administration form
US20040223921A1 (en) 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
US20050074489A1 (en) 2003-10-01 2005-04-07 Pediamed Pharmaceuticals, Inc. Effervescent and effervescent-dispersion compositions for medicaments and methods of use thereof
ITMI20040242U1 (it) 2004-05-24 2004-08-24 Istituto Pirri S R L Contenitore per compresse effervescenti
US20060078509A1 (en) 2004-10-13 2006-04-13 Cadbury Adams Usa Llc Effervescent pressed gum tablet compositions
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
EP2189154A1 (en) 2008-11-25 2010-05-26 Gnosis S.p.A. Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof
CN101966165B (zh) 2009-07-14 2012-06-13 无锡健而乐医药科技有限公司 口腔吸收固体泡腾制剂
WO2011113965A1 (es) 2010-03-18 2011-09-22 Farmalider, S.A. Composición farmacéutica en forma sólida que contiene isoflavonas, una sal de calcio y vitamina d3
CN102232967A (zh) * 2010-04-21 2011-11-09 武汉同济现代医药有限公司 一种新型口服补钙泡腾剂及其制备方法
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form

Also Published As

Publication number Publication date
MX2014015253A (es) 2015-03-05
CN104363897A (zh) 2015-02-18
US20190262392A1 (en) 2019-08-29
WO2013188483A1 (en) 2013-12-19
EP2734192A1 (en) 2014-05-28
CA2876062C (en) 2017-09-12
BR112014030680B1 (pt) 2022-08-30
CA2876062A1 (en) 2013-12-19
AU2013274378B2 (en) 2016-06-02
IN2014DN10385A (pl) 2015-08-14
AU2013274378A1 (en) 2015-01-15
US10617714B2 (en) 2020-04-14
RU2014149581A (ru) 2016-07-10
ES2541723T3 (es) 2015-07-24
BR112014030680A2 (pt) 2017-06-27
MX368363B (es) 2019-09-30
EP2734192B1 (en) 2015-04-15

Similar Documents

Publication Publication Date Title
IL273076A (en) Solid dosage form
PL3181128T3 (pl) Kompozycja farmaceutyczna nilotynibu
ZA201304158B (en) Dosage form
EP2828177A4 (en) DISTRIBUTOR
PL2934259T3 (pl) Dozownik
SI2877155T1 (sl) Opioidne formulacije
GB201414334D0 (en) Auto-refill single dose dispenser
EP2866626A4 (en) DISTRIBUTOR
ZA201405797B (en) Pharmaceutical dosage form
GB201205164D0 (en) Pharmaceutical compounds
IL235830A0 (en) New dosage and formulation
EP2842553A4 (en) ANALGESIC
PL2925366T3 (pl) Kombinacje farmaceutyczne
GB201218012D0 (en) Dosage forms
GB201420971D0 (en) Therapeutic composition
GB201118334D0 (en) Novel dosage form
ZA201501864B (en) Dispensers
HUE039260T2 (hu) Adagoló
IL239512A0 (en) Pharmaceutical compounds
EP2953450A4 (en) DONOR
AP2015008470A0 (en) Dispenser
AP00457S1 (en) Dispenser
EP2804853A4 (en) THERAPEUTIC USES
GB201202027D0 (en) Pharmaceutical compounds
IL236873A0 (en) therapeutic compounds